Overview

Nitrate and Hypertension in Heart Transplanted Patients

Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
0
Participant gender:
All
Summary
The aim of the study was to evaluate the acute effect of nitroglycerine infusion on blood pressure and heart rate in heart-transplanted patients with cyclosporine-induced hypertension.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Zurich
Treatments:
Cyclosporine
Cyclosporins
Nitroglycerin
Criteria
Inclusion Criteria:

- Heart-transplanted group:

- Patients with hypertension and treated with cyclosporine

- Patients under optimal standard therapy

- Patients giving written informed consent

Control group:

- Patients with hypertension

- Patients without prior transplantation of any kind

- Patients giving written informed consent

Exclusion criteria:

- Hypertensive patients receiving immunosuppressive drugs

- Patients receiving any kind or nitrate derivates